Akeso Management
Management criteria checks 3/4
Akeso's CEO is Michelle Xia, appointed in Mar 2012, has a tenure of 12.75 years. total yearly compensation is CN¥6.52M, comprised of 67% salary and 33% bonuses, including company stock and options. directly owns 8.53% of the company’s shares, worth HK$4.66B. The average tenure of the management team and the board of directors is 2.1 years and 5.1 years respectively.
Key information
Michelle Xia
Chief executive officer
CN¥6.5m
Total compensation
| CEO salary percentage | 67.0% |
| CEO tenure | 12.8yrs |
| CEO ownership | 8.5% |
| Management average tenure | 2.1yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥735m |
| Mar 31 2024 | n/a | n/a | CN¥646m |
| Dec 31 2023 | CN¥7m | CN¥4m | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥409m |
| Dec 31 2022 | CN¥5m | CN¥4m | -CN¥1b |
| Sep 30 2022 | n/a | n/a | -CN¥1b |
| Jun 30 2022 | n/a | n/a | -CN¥1b |
| Mar 31 2022 | n/a | n/a | -CN¥1b |
| Dec 31 2021 | CN¥7m | CN¥4m | -CN¥1b |
| Sep 30 2021 | n/a | n/a | -CN¥1b |
| Jun 30 2021 | n/a | n/a | -CN¥929m |
| Mar 31 2021 | n/a | n/a | -CN¥983m |
| Dec 31 2020 | CN¥7m | CN¥3m | -CN¥1b |
| Sep 30 2020 | n/a | n/a | -CN¥870m |
| Jun 30 2020 | n/a | n/a | -CN¥703m |
| Mar 31 2020 | n/a | n/a | -CN¥492m |
| Dec 31 2019 | CN¥2m | CN¥1m | -CN¥282m |
Compensation vs Market: Michelle's total compensation ($USD894.18K) is about average for companies of similar size in the Hong Kong market ($USD848.16K).
Compensation vs Earnings: Michelle's compensation has increased whilst the company is unprofitable.
CEO
Michelle Xia (57 yo)
12.8yrs
Tenure
CN¥6,524,000
Compensation
Dr. Yu Xia, Ph D., also known as Michelle, is CEO & President of Akeso Biopharma, Inc. Dr. Xia is Founder of Akeso, Inc. Dr. Xia is CEO, President & Chairwoman of Akeso, Inc. from March 19, 2012. She has b...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 12.8yrs | CN¥6.52m | 8.53% HK$ 4.7b | |
| Co-Founder | 12.8yrs | CN¥5.02m | 5.65% HK$ 3.1b | |
| Co-Founder | no data | CN¥3.60m | 4.81% HK$ 2.6b | |
| Senior Vice President | less than a year | CN¥33.65m | no data | |
| Co-Founder | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Vice President | 4.4yrs | no data | no data | |
| Senior Vice President | 2.9yrs | no data | no data | |
| Senior Vice President | 1.9yrs | no data | no data | |
| Senior Vice President | 1.9yrs | no data | no data | |
| Senior VP & Chief Commercial Officer | less than a year | no data | no data | |
| Company Secretary | 2.3yrs | no data | no data |
2.1yrs
Average Tenure
55yo
Average Age
Experienced Management: 9926's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 12.8yrs | CN¥6.52m | 8.53% HK$ 4.7b | |
| Co-Founder | 5.1yrs | CN¥5.02m | 5.65% HK$ 3.1b | |
| Co-Founder | 5.1yrs | CN¥3.60m | 4.81% HK$ 2.6b | |
| Co-Founder | less than a year | no data | no data | |
| Independent Non-Executive Director | no data | CN¥317.00k | no data | |
| Non-Executive Director | 4.3yrs | no data | no data | |
| Independent Non-Executive Director | no data | CN¥319.00k | no data | |
| Independent Non-Executive Director | no data | CN¥317.00k | no data |
5.1yrs
Average Tenure
55yo
Average Age
Experienced Board: 9926's board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 23:20 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Akeso, Inc. is covered by 38 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yonglin Yan | BOCI Research Ltd. |
| Sharon Shi | BOCI Research Ltd. |
| Jiangqiao Tong | BOCI Research Ltd. |